RNA 反义纯化技术(RNA Antisense Purification,RAP)用于研究RNA与RNA、RNA与蛋白质之间的相互作用。根据研究对象不同,RAP技术结合了高通量测序(RAP-Seq)和质谱技术(RAP-MS),分别研究与目标RNA互作的RNA和蛋白质。 (本试剂盒仅供科研用途)
实验原理:
RAP技术通过设计生物素探针组拉取目标RNA,使与其共同作用的RNA或蛋白质(RBPs)富集在磁珠上并被洗脱。最后,通过高通量测序得到该调控RNA转录调控的下游靶基因,同时,也可以通过Western Blot验证RBPs,或通过MS鉴定未知蛋白。
产品优势:
1. 伯信独立研发,具有自主知识产权。
2. 灵敏度高,稳定性好。
3. 检测方法领先,结果准确、重复性好。
技术路线:

结果案例:
详见产品说明书:Bes5103-3 RAP-RNA Protein
注:Bes5103-3 RAP-RNA&Protein (同时拉RNA结合RNA和蛋白)的用户可根据实验目的自行参考说明书Bes5103-1 RAP-RNA(只研究RNA结合RNA) 或Bes5103-2 RAP-Protein (只研究RNA结合蛋白)进行实验操作。
文章案例
【2026年】
Article:CircROR1 binds HNRNPL to regulate FOXO4 pre-mRNA splicing, promoting cutaneous melanoma metastasis and serving as a therapeutic target via RNAi-loaded PEG-LNPs
Periodicals:Molecular Cancer
IF:33.8990
Article:DNMT2 inhibits anaplastic thyroid cancer progression by downregulating 5’tiRNAGly-GCC production
Periodicals:Cell Death & Disease
IF:9.5998
Article:IGF2BP3 promotes progression of head and neck cancers through the circHECTD2
Periodicals:Molecular Cancer
IF:33.8990
Article:N4-acetylcytidine in LncRNA Gm26917 Promotes Translation in Female Germline Stem Cells
Periodicals:Advanced Science
IF:14.1
Article:The circular RNA circANK suppresses rice resistance to bacterial blight
Periodicals:The Plant Cell
IF:11.6000
Article:The ANXA2P1-hnRNP F-HK2c-Myc Positive Feedback
Periodicals:International Journal of Biological Sciences
IF:9.9995
Periodicals:Cellular and Molecular Life Sciences
IF:6.2001
【2025年】
Article:CircROR1 binds HNRNPL to regulate FOXO4 pre-mRNA splicing, promoting cutaneous melanoma metastasis and serving as a therapeutic target via RNAi-loaded PEG-LNPs
Periodicals:Molecular Cancer
IF:33.8990
Periodicals:Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
IF:15.800
Periodicals:Acta Pharmaceutica Sinica B
IF:14.700
Periodicals:Advanced Science (Weinheim, Baden-Wurttemburg, Germany)
IF:14.100
Periodicals:Advanced Science (Weinheim, Baden-Wurttemburg, Germany)
IF:14.100
Periodicals:Science Advances
IF:12.500
Periodicals:Proceedings of the National Academy of Sciences of the United States of America
IF:9.100
Periodicals:Cell Death & Disease
IF:8.100
Article:piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.
Periodicals:NPJ Precision Oncology
IF:6.800
【2024年】
Article: Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer.
Periodicals:Molecular cancer
IF:27.700
Periodicals:Molecular cancer
IF:27.700
Periodicals:Advanced Science
IF:14.300
Article:circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis.
Periodicals:Redox biology
IF:10.700
Periodicals:Cancer Letters
IF:9.100
Periodicals:Cell death & disease
IF:8.100
【2023年】
Periodicals:Translational Neurodegeneration
IF:12.600
Periodicals:Cellular & molecular biology letters
IF:9.200
Periodicals:Journal of Translational Medicine
IF:7.400
【2022年】
Periodicals:Molecular Cancer
IF:37.300
Periodicals:Journal of Experimental & Clinical Cancer Research
IF:11.300
Periodicals:Cell Death and Disease
IF:9.000
Periodicals:Cell Death and Disease
IF:8.469
Periodicals:Molecular Therapy: Oncolytics
IF:6.311



